| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 21,576 | 33,611 | | Cost of Revenue |
-
|
-
| | | Gross Profit | 21,576 | 33,611 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 800 | 760 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 20,776 | 32,852 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| | Earnings Before Interest And Taxes | 20,776 | 32,852 | | Interest Expense |
-
|
-
| | Income Before Tax | 20,776 | 32,852 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 20,776 | 32,852 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 20,776 | 32,852 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $20,776 | $32,852 |
|
0.98% Nasdaq 
Income Statement
